Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DNM1 | Q05193 | 8/20 | 1.00 |
| ▸ | TSHR | P16473 | 2/20 | 0.73 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.73 |
| ▸ | THRB | P10828 | 1/20 | 0.53 |
| ▸ | CA12 | O43570 | 1/20 | 0.44 |
| ▸ | CA1 | P00915 | 1/20 | 0.44 |
| ▸ | CA2 | P00918 | 1/20 | 0.44 |
| ▸ | CA9 | Q16790 | 1/20 | 0.44 |
| ▸ | S1PR2 | O95136 | 1/20 | 0.43 |
| ▸ | S1PR1 | P21453 | 1/20 | 0.43 |
| ▸ | S1PR3 | Q99500 | 1/20 | 0.43 |
| ▸ | S1PR5 | Q9H228 | 1/20 | 0.43 |
| ▸ | GBA1 | P04062 | 1/20 | 0.41 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL108754 | 1.00 | DNM1 (1.00) | DNM1TSHRALDH1A1THRBCA12 | |
| SCHEMBL753044 | 1.00 | DNM1 (1.00) | DNM1TSHRALDH1A1THRBCA12 | |
| SCHEMBL109289 | 1.00 | DNM1 (1.00) | DNM1TSHRALDH1A1THRBCA12 | |
| SCHEMBL6104785 | 1.00 | DNM1 (1.00) | DNM1TSHRALDH1A1THRBCA12 | |
| SCHEMBL614393 | 1.00 | DNM1 (1.00) | DNM1TSHRALDH1A1THRBCA12 | |
| Dymanthine SCHEMBL8744671 | 1.00 | DNM1 (1.00) | DNM1TSHRALDH1A1THRBCA12 | |
| SCHEMBL25269808 | 1.00 | DNM1 (1.00) | DNM1TSHRALDH1A1THRBCA12 | |
| SCHEMBL8463347 | 1.00 | — | — | |
| SCHEMBL158743 | 1.00 | — | — | |
| SCHEMBL284474 | 1.00 | DNM1 (1.00) | DNM1TSHRALDH1A1THRBCA12 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 991 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4642829-B1 | EPOXIDE-BASED COMPOSITION | EVONIK OPERATIONS GMBH (DE) | 2026-05-27 | — | — | EP | claimed |
| EP-4642829-A1 | EPOXIDE-BASED COMPOSITION | Evonik Operations GmbH (DE) | 2025-11-05 | — | — | EP | claimed |
| WO-2024141243-A1 | EPOXIDE-BASED COMPOSITION | EVONIK OPERATIONS GMBH (DE) | 2024-07-04 | — | — | WO | claimed |
| CN-117690657-A | Use of accelerator in preparation of low-temperature cured slurry and application of low-temperature cured slurry | 隆基绿能科技股份有限公司 | 2024-03-12 | — | — | CN | claimed |
| CN-117487135-A | Curing agent, curing composition and application thereof | 隆基绿能科技股份有限公司 | 2024-02-02 | — | — | CN | claimed |
| CN-117463409-A | Preparation method and application of fixed bed hydrogenation catalyst | 万华化学集团股份有限公司 | 2024-01-30 | — | — | CN | claimed |
| CN-117438131-A | Use of accelerator in preparation of low-temperature cured silver paste and application of low-temperature cured silver paste | 隆基绿能科技股份有限公司 | 2024-01-23 | — | — | CN | claimed |
| WO-2023101060-A1 | QUANTUM DOTS AND METHOD FOR PRODUCING SAME | 주식회사 제우스 | 2023-06-08 | — | — | WO | claimed |
| CN-109072067-B | Quantum dot and preparation method thereof | 杰宜斯科技有限公司 | 2022-06-03 | — | — | CN | claimed |
| CN-112608263-B | Tellurium organic complex, preparation method thereof and tellurium-doped liquid scintillator containing complex | 中国科学院高能物理研究所 | 2022-05-27 | — | — | CN | claimed |
| WO-2002092139-A1 | METHODS FOR INACTIVATING VIRUSES | AKZO NOBEL N.V. (NL) | 2002-11-21 | — | — | WO | claimed |
| US-20020169214-A1 | Methods and compositions for inactivating viruses | N.V. ORGANON (NL) | 2002-11-14 | — | — | US | claimed |
| WO-2002057478-A1 | METHODS AND COMPOSITIONS FOR EXTRACTING PROTEINS FROM CELLS | AKZO NOBEL N.V. (US) | 2002-07-25 | — | — | WO | claimed |
| US-6423768-B1 | MIXTURES CONTAINING POLYAMIDES, POLYPHENYLENE ETHER AND IMPACT STRENGTH ADJUVANTS | GENERAL ELECTRIC COMPANY | 2002-07-23 | — | — | US | claimed |
| WO-2002022729-A1 | POLYMER-ORGANOCLAY COMPOSITE COMPOSITIONS, METHOD FOR MAKING AND ARTICLES THEREFROM | GENERAL ELECTRIC COMPANY (US) | 2002-03-21 | — | — | WO | claimed |
| CN-1264430-A | Betaines as adjuvants to susceptibility testing and antimicrobial therapy | INTEGRATED RES TECHNOLOGY PLC (US) | 2000-08-23 | — | — | CN | claimed |
| EP-1014193-A1 | Photoresist compositions suitable for deep-UV wavelength imaging | Shipley Company LLC (US) | 2000-06-28 | — | — | EP | claimed |
| CN-1150460-A | Method for processing mycobacteria | CORNING CLINICAL LAB INC (US) | 1997-05-21 | — | — | CN | claimed |
| EP-0126743-B1 | SURFACTANT TREATMENT OF IMPLANTABLE BIOLOGICAL TISSUE TO INHIBIT CALCIFICATION | BAXTER INTERNATIONAL INC. (a Delaware corporation) (US) | 1989-04-12 | — | — | EP | claimed |
| US-4027020-A | ANTIMICROBIALS FROM 1,4-DIHALO-2-BUTENE AND A MONO- AND A DI-FUNCTIONAL TERTIARY AMINE | MILLMASTER ONYX CORPORATION (US) | 1977-05-31 | — | — | US | claimed |